Study #2024-0064
A PrOspeCtive, post-approval, open-label, multi-center united states (US) registry to EvaLUate the effectiveness and safety of ObsiDio in clinical PracticE
MD Anderson Study Status
Enrolling
Treatment Agent
Description
OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic. The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Hypervascular Tumors;Bleeding;Hemorrhage
Study phase:
Physician name:
Ketan Shah
Department:
Interventional Radiology
For general questions about clinical trials:
1-844-918-4713
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.